October 7, 2009 – $1.2 Million Gift Establishes Mark S. Kahn Family Medical Innovation Fund at U-M MICPosted on October 9th, 2009 No comments
The U-M Medical Innovation Center (MIC) is pleased to announce the creation of the Mark S. Kahn Family Medical Innovation Fund. The new $1.2 million fund will support leading edge biomedical research and entrepreneurship at the MIC.
Mark (U-M BBS 1974) and his wife, Judy, are active philanthropists, investing in numerous nonprofit ventures. Mark is the former president of Production Tool Supply Company and is passionate about the MIC’s vision to bring together engineering, business and a wide range of medical professionals to collaborate on state-of-the-art medical innovation. Mark plans to remain engaged in the MIC and is excited to lend his expertise in tool design and manufacturing to MIC projects. Mark and Judy live in Encino, CA.
“The energy and enthusiasm from the MIC will be a catalyst for many new medical inventions”, says Kahn. “It will be exciting to see how the combined efforts from the various UM departments will bring these ideas to the marketplace.”
About the MIC
Founded in the spring of 2008, the MIC’s mission is to foster innovation and enable new medical technologies by bringing clinicians, scientists, engineers, and business professionals together through education and research to, ultimately, improve health on a global scale.
Each year, a select number of fellows train at the MIC. The multidisciplinary curriculum is designed to provide the skills and resources necessary to turn an idea into a prototype, bring it successfully to market, and offer critical advancements to a particular medical specialty. Already the MIC’s program is creating results. After graduating this past June, the MIC’s first cohort of fellows have founded two companies: Tangent Medical, to develop a better technique for IV catheter design (patent pending) and Trinity Medical to develop a spine surgery device (patent pending).
For more information about the MIC or the Mark S. Kahn Family Medical Innovation Fund, please contact Ann Boyd-Stewart.